SMAD2 and hepatocellular carcinoma: These results indicate that proHp-stimulated Smad1/5 activation is directly related to inhibition of the Smad2/3 signaling pathway, suggesting that proHp participates in regulatory interactions between these two Smad signaling pathways in SK-Hep1 hepatoma cells.